Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Enterovirus Persistence in Cardiac Cells of Patients Suffering From Idiopathic Dilated Cardiomyopathy is Linked to 5' Terminal Genomic RNA-Deleted Viral Populations With Viral-Encoded Proteinase Activities.

Bouin A, Gretteau PA, Wehbe M, Renois F, N'Guyen Y, Leveque N, Vu MN, Tracy S, Chapman NM, Bruneval P, Fornes P, Semler BL, Andreoletti L.

Circulation. 2019 Feb 13. doi: 10.1161/CIRCULATIONAHA.118.035966. [Epub ahead of print]

PMID:
30755025
2.

Upregulation of PD-L1 via HMGB1-activated IRF3 and NF-kB contributes to UV radiation-induced immune suppression.

Wang W, Chapman NM, Zhang B, Li M, Fan M, Laribee RN, Zaidi MR, Pfeffer LM, Chi H, Wu ZH.

Cancer Res. 2019 Feb 8. pii: canres.3134.2018. doi: 10.1158/0008-5472.CAN-18-3134. [Epub ahead of print]

PMID:
30737234
3.

Emerging Roles of Cellular Metabolism in Regulating Dendritic Cell Subsets and Function.

Du X, Chapman NM, Chi H.

Front Cell Dev Biol. 2018 Nov 13;6:152. doi: 10.3389/fcell.2018.00152. eCollection 2018. Review.

4.

mTOR coordinates transcriptional programs and mitochondrial metabolism of activated Treg subsets to protect tissue homeostasis.

Chapman NM, Zeng H, Nguyen TM, Wang Y, Vogel P, Dhungana Y, Liu X, Neale G, Locasale JW, Chi H.

Nat Commun. 2018 May 29;9(1):2095. doi: 10.1038/s41467-018-04392-5.

5.

Hallmarks of T-cell Exit from Quiescence.

Chapman NM, Chi H.

Cancer Immunol Res. 2018 May;6(5):502-508. doi: 10.1158/2326-6066.CIR-17-0605.

PMID:
29716982
6.

Complete Genome Sequence of the Circular Extrachromosomal Element of Naegleria gruberi Strain EGB Ribosomal DNA.

Mullican JC, Chapman NM, Tracy S.

Genome Announc. 2018 Feb 8;6(6). pii: e00020-18. doi: 10.1128/genomeA.00020-18.

7.

Metabolism in Immune Cell Differentiation and Function.

Chapman NM, Shrestha S, Chi H.

Adv Exp Med Biol. 2017;1011:1-85. doi: 10.1007/978-94-024-1170-6_1.

PMID:
28875486
8.

Dietary Fat Inflames CD4+ T Cell Memory in Obesity.

Chapman NM, Chi H.

Cell Metab. 2017 Mar 7;25(3):490-492. doi: 10.1016/j.cmet.2017.02.012.

9.

Corrigendum: Three capsid amino acids notably influence coxsackie B3 virus stability.

Carson SD, Tracy S, Kaczmarek ZG, Alhazmi A, Chapman NM.

J Gen Virol. 2017 Jan;98(1):126-127. doi: 10.1099/jgv.0.000732. No abstract available.

PMID:
28218574
10.

Prior immune exposure can protect or can enhance pathology in the enteroviruses: what predicts the outcome?

Chapman NM.

Virulence. 2017 Aug 18;8(6):643-645. doi: 10.1080/21505594.2016.1269048. Epub 2016 Dec 9. No abstract available.

11.

Pretreatment of activated human CD8 T cells with IL-12 leads to enhanced TCR-induced signaling and cytokine production.

Vacaflores A, Freedman SN, Chapman NM, Houtman JC.

Mol Immunol. 2017 Jan;81:1-15. doi: 10.1016/j.molimm.2016.11.008. Epub 2016 Nov 22.

12.

Domain I of the 5' non-translated genomic region in coxsackievirus B3 RNA is not required for productive replication.

Jaramillo L, Smithee S, Tracy S, Chapman NM.

Virology. 2016 Sep;496:127-130. doi: 10.1016/j.virol.2016.05.021. Epub 2016 Jun 9.

13.

Exposure of Human CD4 T Cells to IL-12 Results in Enhanced TCR-Induced Cytokine Production, Altered TCR Signaling, and Increased Oxidative Metabolism.

Vacaflores A, Chapman NM, Harty JT, Richer MJ, Houtman JC.

PLoS One. 2016 Jun 9;11(6):e0157175. doi: 10.1371/journal.pone.0157175. eCollection 2016.

14.

Reversion to wildtype of a mutated and nonfunctional coxsackievirus B3CRE(2C).

Smithee S, Tracy S, Chapman NM.

Virus Res. 2016 Jul 15;220:136-49. doi: 10.1016/j.virusres.2016.04.016. Epub 2016 Apr 26.

15.

Three capsid amino acids notably influence coxsackie B3 virus stability.

Carson SD, Tracy S, Kaczmarek ZG, Alhazmi A, Chapman NM.

J Gen Virol. 2016 Jan;97(1):60-8. doi: 10.1099/jgv.0.000319. Epub 2015 Oct 20. Erratum in: J Gen Virol. 2017 Jan;98(1):126-127.

PMID:
26489722
16.

Mutational Disruption of cis-Acting Replication Element 2C in Coxsackievirus B3 Leads to 5'-Terminal Genomic Deletions.

Smithee S, Tracy S, Chapman NM.

J Virol. 2015 Dec;89(23):11761-72. doi: 10.1128/JVI.01308-15. Epub 2015 Sep 9.

17.

mTOR and metabolic regulation of conventional and regulatory T cells.

Liu C, Chapman NM, Karmaus PW, Zeng H, Chi H.

J Leukoc Biol. 2015 May;97(5):837-847. doi: 10.1189/jlb.2RI0814-408R. Epub 2015 Feb 24. Review.

18.

mTOR Links Environmental Signals to T Cell Fate Decisions.

Chapman NM, Chi H.

Front Immunol. 2015 Jan 20;5:686. doi: 10.3389/fimmu.2014.00686. eCollection 2014. Review.

19.

mTOR signaling, Tregs and immune modulation.

Chapman NM, Chi H.

Immunotherapy. 2014;6(12):1295-311. doi: 10.2217/imt.14.84. Review.

20.

Proline-rich tyrosine kinase 2 controls PI3-kinase activation downstream of the T cell antigen receptor in human T cells.

Chapman NM, Yoder AN, Barbón KM, Bilal MY, Connolly SF, Houtman JC.

J Leukoc Biol. 2015 Feb;97(2):285-96. doi: 10.1189/jlb.2A1013-568RRR. Epub 2014 Nov 11.

21.

Functions of the FAK family kinases in T cells: beyond actin cytoskeletal rearrangement.

Chapman NM, Houtman JC.

Immunol Res. 2014 Aug;59(1-3):23-34. doi: 10.1007/s12026-014-8527-y. Review.

22.

Focal adhesion kinase negatively regulates Lck function downstream of the T cell antigen receptor.

Chapman NM, Connolly SF, Reinl EL, Houtman JC.

J Immunol. 2013 Dec 15;191(12):6208-21. doi: 10.4049/jimmunol.1301587. Epub 2013 Nov 13.

23.

The diagnosis of insulitis in human type 1 diabetes.

Campbell-Thompson ML, Atkinson MA, Butler AE, Chapman NM, Frisk G, Gianani R, Giepmans BN, von Herrath MG, Hyöty H, Kay TW, Korsgren O, Morgan NG, Powers AC, Pugliese A, Richardson SJ, Rowe PA, Tracy S, In't Veld PA.

Diabetologia. 2013 Nov;56(11):2541-3. doi: 10.1007/s00125-013-3043-5. Epub 2013 Sep 5. No abstract available.

PMID:
24006089
24.

Non-catalytic functions of Pyk2 and Fyn regulate late stage adhesion in human T cells.

Chapman NM, Yoder AN, Houtman JC.

PLoS One. 2012;7(12):e53011. doi: 10.1371/journal.pone.0053011. Epub 2012 Dec 27.

25.

Distinct signaling pathways regulate TLR2 co-stimulatory function in human T cells.

Chapman NM, Bilal MY, Cruz-Orcutt N, Knudson C, Madinaveitia S, Light J, Houtman JC.

Cell Signal. 2013 Mar;25(3):639-50. doi: 10.1016/j.cellsig.2012.11.026. Epub 2012 Dec 5.

26.

The microbiology of human hygiene and its impact on type 1 diabetes.

Chapman NM, Coppieters K, von Herrath M, Tracy S.

Islets. 2012 Jul-Aug;4(4):253-61. doi: 10.4161/isl.21570. Epub 2012 Jul 1. Review.

27.

Enteroviruses and type 1 diabetes.

Tracy S, Drescher KM, Chapman NM.

Diabetes Metab Res Rev. 2011 Nov;27(8):820-3. doi: 10.1002/dmrr.1255.

PMID:
22069266
28.

Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment.

Carson SD, Chapman NM, Hafenstein S, Tracy S.

J Virol. 2011 Apr;85(7):3306-14. doi: 10.1128/JVI.01827-10. Epub 2011 Jan 26.

29.

Functional role of the 5' terminal cloverleaf in Coxsackievirus RNA replication.

Sharma N, Ogram SA, Morasco BJ, Spear A, Chapman NM, Flanegan JB.

Virology. 2009 Oct 25;393(2):238-49. doi: 10.1016/j.virol.2009.07.039. Epub 2009 Sep 3.

30.

5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart.

Chapman NM, Kim KS, Drescher KM, Oka K, Tracy S.

Virology. 2008 Jun 5;375(2):480-91. doi: 10.1016/j.virol.2008.02.030. Epub 2008 Apr 1.

31.

Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy.

Chapman NM, Kim KS.

Curr Top Microbiol Immunol. 2008;323:275-92. Review.

PMID:
18357775
32.

Replication of coxsackievirus B3 in primary cell cultures generates novel viral genome deletions.

Kim KS, Chapman NM, Tracy S.

J Virol. 2008 Feb;82(4):2033-7. Epub 2007 Dec 5.

33.

Endogenous low-level expression of the coxsackievirus and adenovirus receptor enables coxsackievirus B3 infection of RD cells.

Carson SD, Kim KS, Pirruccello SJ, Tracy S, Chapman NM.

J Gen Virol. 2007 Nov;88(Pt 11):3031-8.

PMID:
17947527
34.

Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.

Kanno T, Kim K, Kono K, Drescher KM, Chapman NM, Tracy S.

J Virol. 2006 Jun;80(11):5637-43. Erratum in: J Virol. 2006 Sep;80(17):8843.

35.

Myocarditis and heart failure associated with hepatitis C virus infection.

Matsumori A, Shimada T, Chapman NM, Tracy SM, Mason JW.

J Card Fail. 2006 May;12(4):293-8.

PMID:
16679263
36.

Evolution of virulence in picornaviruses.

Tracy S, Chapman NM, Drescher KM, Kono K, Tapprich W.

Curr Top Microbiol Immunol. 2006;299:193-209. Review.

PMID:
16568900
37.

National Institutes of Health-sponsored workshop on inflammation and immunity in dilated cardiomyopathy.

Cooper LT, Virmani R, Chapman NM, Frustaci A, Rodeheffer RJ, Cunningham MW, McNamara DM.

Mayo Clin Proc. 2006 Feb;81(2):199-204.

PMID:
16471075
38.
39.

Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate.

Lee CK, Kono K, Haas E, Kim KS, Drescher KM, Chapman NM, Tracy S.

J Gen Virol. 2005 Jan;86(Pt 1):197-210.

PMID:
15604447
40.

Monoclonal antibody against mouse CAR following genetic immunization.

Carson SD, Switzer BL, Tracy SM, Chapman NM.

Hybrid Hybridomics. 2004 Feb;23(1):19-22.

PMID:
15000844
41.

The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.

Dunn JJ, Bradrick SS, Chapman NM, Tracy SM, Romero JR.

J Infect Dis. 2003 May 15;187(10):1552-61. Epub 2003 Apr 30.

PMID:
12721935
43.

Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

Tracy S, Drescher KM, Chapman NM, Kim KS, Carson SD, Pirruccello S, Lane PH, Romero JR, Leser JS.

J Virol. 2002 Dec;76(23):12097-111.

44.

The group B coxsackieviruses and myocarditis.

Kim KS, Hufnagel G, Chapman NM, Tracy S.

Rev Med Virol. 2001 Nov-Dec;11(6):355-68. Review.

PMID:
11746998
45.

Coxsackievirus and adenovirus receptor (CAR) binds immunoglobulins.

Carson SD, Chapman NM.

Biochemistry. 2001 Dec 4;40(48):14324-9.

PMID:
11724543
46.

A group B coxsackievirus/poliovirus 5' nontranslated region chimera can act as an attenuated vaccine strain in mice.

Chapman NM, Ragland A, Leser JS, Höfling K, Willian S, Semler BL, Tracy S.

J Virol. 2000 May;74(9):4047-56.

47.

Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice.

Chapman NM, Kim KS, Tracy S, Jackson J, Höfling K, Leser JS, Malone J, Kolbeck P.

J Virol. 2000 Sep;74(17):7952-62.

48.

Progress toward vaccines against viruses that cause heart disease.

Höfling K, Kim KS, Leser JS, Chapman NM, Willian S, Gauntt CJ, Tracy S.

Herz. 2000 May;25(3):286-90. Review.

PMID:
10904854
49.

Supplemental Content

Loading ...
Support Center